JP2011020929A - Foamable aerosol composition - Google Patents
Foamable aerosol composition Download PDFInfo
- Publication number
- JP2011020929A JP2011020929A JP2009165038A JP2009165038A JP2011020929A JP 2011020929 A JP2011020929 A JP 2011020929A JP 2009165038 A JP2009165038 A JP 2009165038A JP 2009165038 A JP2009165038 A JP 2009165038A JP 2011020929 A JP2011020929 A JP 2011020929A
- Authority
- JP
- Japan
- Prior art keywords
- aerosol composition
- water
- stock solution
- oil
- foamable aerosol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000443 aerosol Substances 0.000 title claims abstract description 79
- 239000000203 mixture Substances 0.000 title claims abstract description 69
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 31
- 239000003995 emulsifying agent Substances 0.000 claims abstract description 21
- 239000004088 foaming agent Substances 0.000 claims abstract description 15
- 239000002904 solvent Substances 0.000 claims abstract description 14
- 239000004094 surface-active agent Substances 0.000 claims abstract description 14
- 239000011550 stock solution Substances 0.000 claims description 78
- -1 fatty acid ester Chemical class 0.000 claims description 48
- 239000003921 oil Substances 0.000 claims description 42
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 34
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 30
- 239000000194 fatty acid Substances 0.000 claims description 30
- 229930195729 fatty acid Natural products 0.000 claims description 30
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 26
- 239000007762 w/o emulsion Substances 0.000 claims description 24
- 239000001569 carbon dioxide Substances 0.000 claims description 17
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 17
- 239000002202 Polyethylene glycol Substances 0.000 claims description 14
- 229920001223 polyethylene glycol Polymers 0.000 claims description 14
- 239000004359 castor oil Substances 0.000 claims description 11
- 235000019438 castor oil Nutrition 0.000 claims description 11
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims description 11
- 229920001214 Polysorbate 60 Polymers 0.000 claims description 9
- 229920001296 polysiloxane Polymers 0.000 claims description 6
- 150000005215 alkyl ethers Chemical class 0.000 claims description 5
- 239000006260 foam Substances 0.000 abstract description 22
- 239000004480 active ingredient Substances 0.000 abstract description 11
- 239000000839 emulsion Substances 0.000 abstract description 9
- 210000002374 sebum Anatomy 0.000 abstract description 8
- 239000002537 cosmetic Substances 0.000 abstract description 5
- 230000007794 irritation Effects 0.000 abstract description 4
- 210000004400 mucous membrane Anatomy 0.000 abstract description 4
- 239000012071 phase Substances 0.000 description 43
- 235000019198 oils Nutrition 0.000 description 36
- 239000007789 gas Substances 0.000 description 27
- 239000008346 aqueous phase Substances 0.000 description 22
- 238000002156 mixing Methods 0.000 description 18
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 14
- 229910052782 aluminium Inorganic materials 0.000 description 14
- 230000000052 comparative effect Effects 0.000 description 10
- 235000019441 ethanol Nutrition 0.000 description 10
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 8
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- 238000005187 foaming Methods 0.000 description 8
- 150000001298 alcohols Chemical class 0.000 description 7
- 229920001577 copolymer Polymers 0.000 description 7
- 150000004665 fatty acids Chemical class 0.000 description 7
- 239000000843 powder Substances 0.000 description 7
- WWZKQHOCKIZLMA-UHFFFAOYSA-N Caprylic acid Natural products CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 6
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 239000003915 liquefied petroleum gas Substances 0.000 description 5
- 229920003169 water-soluble polymer Polymers 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 4
- CRZQGDNQQAALAY-UHFFFAOYSA-N Methyl benzeneacetate Chemical compound COC(=O)CC1=CC=CC=C1 CRZQGDNQQAALAY-UHFFFAOYSA-N 0.000 description 4
- OGELJRHPEZALCC-UHFFFAOYSA-N [3-(2,3-dihydroxypropoxy)-2-hydroxypropyl] dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCC(O)COCC(O)CO OGELJRHPEZALCC-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- QUKGYYKBILRGFE-UHFFFAOYSA-N benzyl acetate Chemical compound CC(=O)OCC1=CC=CC=C1 QUKGYYKBILRGFE-UHFFFAOYSA-N 0.000 description 4
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- 229940119170 jojoba wax Drugs 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000008406 cosmetic ingredient Substances 0.000 description 3
- 150000005690 diesters Chemical class 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 3
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 3
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 3
- 229960002216 methylparaben Drugs 0.000 description 3
- 239000007764 o/w emulsion Substances 0.000 description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
- 235000013772 propylene glycol Nutrition 0.000 description 3
- 229960004063 propylene glycol Drugs 0.000 description 3
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 2
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- 239000000263 2,3-dihydroxypropyl (Z)-octadec-9-enoate Substances 0.000 description 2
- QGLVWTFUWVTDEQ-UHFFFAOYSA-N 2-chloro-3-methoxyphenol Chemical compound COC1=CC=CC(O)=C1Cl QGLVWTFUWVTDEQ-UHFFFAOYSA-N 0.000 description 2
- MUHFRORXWCGZGE-KTKRTIGZSA-N 2-hydroxyethyl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCCO MUHFRORXWCGZGE-KTKRTIGZSA-N 0.000 description 2
- ICIDSZQHPUZUHC-UHFFFAOYSA-N 2-octadecoxyethanol Chemical compound CCCCCCCCCCCCCCCCCCOCCO ICIDSZQHPUZUHC-UHFFFAOYSA-N 0.000 description 2
- RZRNAYUHWVFMIP-GDCKJWNLSA-N 3-oleoyl-sn-glycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](O)CO RZRNAYUHWVFMIP-GDCKJWNLSA-N 0.000 description 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- KWOLFJPFCHCOCG-UHFFFAOYSA-N Acetophenone Chemical compound CC(=O)C1=CC=CC=C1 KWOLFJPFCHCOCG-UHFFFAOYSA-N 0.000 description 2
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- GQPLMRYTRLFLPF-UHFFFAOYSA-N Nitrous Oxide Chemical compound [O-][N+]#N GQPLMRYTRLFLPF-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- IYFATESGLOUGBX-YVNJGZBMSA-N Sorbitan monopalmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O IYFATESGLOUGBX-YVNJGZBMSA-N 0.000 description 2
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000003945 anionic surfactant Substances 0.000 description 2
- 229940121363 anti-inflammatory agent Drugs 0.000 description 2
- 239000002260 anti-inflammatory agent Substances 0.000 description 2
- 229940007550 benzyl acetate Drugs 0.000 description 2
- SWQUTKGVXGTROS-UHFFFAOYSA-N bis(2-ethoxyethyl) butanedioate Chemical compound CCOCCOC(=O)CCC(=O)OCCOCC SWQUTKGVXGTROS-UHFFFAOYSA-N 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 229940119676 diethoxyethyl succinate Drugs 0.000 description 2
- 239000010696 ester oil Substances 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 125000002350 geranyl group Chemical group [H]C([*])([H])/C([H])=C(C([H])([H])[H])/C([H])([H])C([H])([H])C([H])=C(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- 229960002989 glutamic acid Drugs 0.000 description 2
- 229940075507 glyceryl monostearate Drugs 0.000 description 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 2
- LVHBHZANLOWSRM-UHFFFAOYSA-N itaconic acid Chemical compound OC(=O)CC(=C)C(O)=O LVHBHZANLOWSRM-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- QPJVMBTYPHYUOC-UHFFFAOYSA-N methyl benzoate Chemical compound COC(=O)C1=CC=CC=C1 QPJVMBTYPHYUOC-UHFFFAOYSA-N 0.000 description 2
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 2
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 2
- RZRNAYUHWVFMIP-UHFFFAOYSA-N monoelaidin Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 229960002446 octanoic acid Drugs 0.000 description 2
- 239000003002 pH adjusting agent Substances 0.000 description 2
- 239000003380 propellant Substances 0.000 description 2
- 229920002545 silicone oil Polymers 0.000 description 2
- 235000011069 sorbitan monooleate Nutrition 0.000 description 2
- 239000001593 sorbitan monooleate Substances 0.000 description 2
- 229940035049 sorbitan monooleate Drugs 0.000 description 2
- 235000011071 sorbitan monopalmitate Nutrition 0.000 description 2
- 239000001570 sorbitan monopalmitate Substances 0.000 description 2
- 229940031953 sorbitan monopalmitate Drugs 0.000 description 2
- 235000011076 sorbitan monostearate Nutrition 0.000 description 2
- 239000001587 sorbitan monostearate Substances 0.000 description 2
- 229940035048 sorbitan monostearate Drugs 0.000 description 2
- 229940100459 steareth-20 Drugs 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 229960000984 tocofersolan Drugs 0.000 description 2
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 1
- DEQUKPCANKRTPZ-UHFFFAOYSA-N (2,3-dihydroxyphenyl)-phenylmethanone Chemical compound OC1=CC=CC(C(=O)C=2C=CC=CC=2)=C1O DEQUKPCANKRTPZ-UHFFFAOYSA-N 0.000 description 1
- ATCDSAIMQFVYAG-UHFFFAOYSA-N (2,3-dihydroxyphenyl)-phenylmethanone;sodium Chemical compound [Na].OC1=CC=CC(C(=O)C=2C=CC=CC=2)=C1O ATCDSAIMQFVYAG-UHFFFAOYSA-N 0.000 description 1
- HJIAMFHSAAEUKR-UHFFFAOYSA-N (2-hydroxyphenyl)-phenylmethanone Chemical compound OC1=CC=CC=C1C(=O)C1=CC=CC=C1 HJIAMFHSAAEUKR-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- BJDAUCLANVMIOB-UHFFFAOYSA-N (3-decanoyloxy-2,2-dimethylpropyl) decanoate Chemical compound CCCCCCCCCC(=O)OCC(C)(C)COC(=O)CCCCCCCCC BJDAUCLANVMIOB-UHFFFAOYSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N (R)-alpha-Tocopherol Natural products OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 1
- MCCACAIVAXEFAL-UHFFFAOYSA-N 1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole;nitric acid Chemical compound O[N+]([O-])=O.ClC1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 MCCACAIVAXEFAL-UHFFFAOYSA-N 0.000 description 1
- CMCBDXRRFKYBDG-UHFFFAOYSA-N 1-dodecoxydodecane Chemical compound CCCCCCCCCCCCOCCCCCCCCCCCC CMCBDXRRFKYBDG-UHFFFAOYSA-N 0.000 description 1
- FDCJDKXCCYFOCV-UHFFFAOYSA-N 1-hexadecoxyhexadecane Chemical compound CCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCC FDCJDKXCCYFOCV-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- HBXWUCXDUUJDRB-UHFFFAOYSA-N 1-octadecoxyoctadecane Chemical compound CCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCC HBXWUCXDUUJDRB-UHFFFAOYSA-N 0.000 description 1
- OVYMWJFNQQOJBU-UHFFFAOYSA-N 1-octanoyloxypropan-2-yl octanoate Chemical compound CCCCCCCC(=O)OCC(C)OC(=O)CCCCCCC OVYMWJFNQQOJBU-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- JMBWBOKFMJWVCU-UHFFFAOYSA-N 1-phenylethanone;tetradecanoic acid Chemical compound CC(=O)C1=CC=CC=C1.CCCCCCCCCCCCCC(O)=O JMBWBOKFMJWVCU-UHFFFAOYSA-N 0.000 description 1
- WAYINTBTZWQNSN-UHFFFAOYSA-N 11-methyldodecyl 3,5,5-trimethylhexanoate Chemical compound CC(C)CCCCCCCCCCOC(=O)CC(C)CC(C)(C)C WAYINTBTZWQNSN-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- FLPJVCMIKUWSDR-UHFFFAOYSA-N 2-(4-formylphenoxy)acetamide Chemical compound NC(=O)COC1=CC=C(C=O)C=C1 FLPJVCMIKUWSDR-UHFFFAOYSA-N 0.000 description 1
- OBETXYAYXDNJHR-UHFFFAOYSA-N 2-Ethylhexanoic acid Chemical compound CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 1
- FKOKUHFZNIUSLW-UHFFFAOYSA-N 2-Hydroxypropyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(C)O FKOKUHFZNIUSLW-UHFFFAOYSA-N 0.000 description 1
- UMHYVXGZRGOICM-AUYXYSRISA-N 2-[(z)-octadec-9-enoyl]oxypropyl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(C)OC(=O)CCCCCCC\C=C/CCCCCCCC UMHYVXGZRGOICM-AUYXYSRISA-N 0.000 description 1
- NLMKTBGFQGKQEV-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-hexadecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO NLMKTBGFQGKQEV-UHFFFAOYSA-N 0.000 description 1
- 229940058020 2-amino-2-methyl-1-propanol Drugs 0.000 description 1
- UXFQFBNBSPQBJW-UHFFFAOYSA-N 2-amino-2-methylpropane-1,3-diol Chemical compound OCC(N)(C)CO UXFQFBNBSPQBJW-UHFFFAOYSA-N 0.000 description 1
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 description 1
- NFIHXTUNNGIYRF-UHFFFAOYSA-N 2-decanoyloxypropyl decanoate Chemical compound CCCCCCCCCC(=O)OCC(C)OC(=O)CCCCCCCCC NFIHXTUNNGIYRF-UHFFFAOYSA-N 0.000 description 1
- ZVUNTIMPQCQCAQ-UHFFFAOYSA-N 2-dodecanoyloxyethyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCCC ZVUNTIMPQCQCAQ-UHFFFAOYSA-N 0.000 description 1
- GLCFQKXOQDQJFZ-UHFFFAOYSA-N 2-ethylhexyl 12-hydroxyoctadecanoate Chemical compound CCCCCCC(O)CCCCCCCCCCC(=O)OCC(CC)CCCC GLCFQKXOQDQJFZ-UHFFFAOYSA-N 0.000 description 1
- JGUMTYWKIBJSTN-UHFFFAOYSA-N 2-ethylhexyl 4-[[4,6-bis[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 JGUMTYWKIBJSTN-UHFFFAOYSA-N 0.000 description 1
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 1
- GHHURQMJLARIDK-UHFFFAOYSA-N 2-hydroxypropyl octanoate Chemical compound CCCCCCCC(=O)OCC(C)O GHHURQMJLARIDK-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- MSPJNHHBNOLHOC-UHFFFAOYSA-N 3,3-dimethylcyclopropane-1,2-dicarboxylic acid Chemical compound CC1(C)C(C(O)=O)C1C(O)=O MSPJNHHBNOLHOC-UHFFFAOYSA-N 0.000 description 1
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-M 5-oxo-L-prolinate Chemical compound [O-]C(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-M 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- DKLGGNTZHFDTAY-UHFFFAOYSA-N C(CC)(=O)O.C(CCCCCCC)C(C1=CC=CC=C1)=C1N(C(C(N1OC)=O)=O)OC Chemical compound C(CC)(=O)O.C(CCCCCCC)C(C1=CC=CC=C1)=C1N(C(C(N1OC)=O)=O)OC DKLGGNTZHFDTAY-UHFFFAOYSA-N 0.000 description 1
- AFWTZXXDGQBIKW-UHFFFAOYSA-N C14 surfactin Natural products CCCCCCCCCCCC1CC(=O)NC(CCC(O)=O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CC(O)=O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)O1 AFWTZXXDGQBIKW-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 235000001815 DL-alpha-tocopherol Nutrition 0.000 description 1
- 239000011627 DL-alpha-tocopherol Substances 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- IUMSDRXLFWAGNT-UHFFFAOYSA-N Dodecamethylcyclohexasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 IUMSDRXLFWAGNT-UHFFFAOYSA-N 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- FPVVYTCTZKCSOJ-UHFFFAOYSA-N Ethylene glycol distearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCCCCCCCCC FPVVYTCTZKCSOJ-UHFFFAOYSA-N 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- SHBUUTHKGIVMJT-UHFFFAOYSA-N Hydroxystearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OO SHBUUTHKGIVMJT-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 235000021360 Myristic acid Nutrition 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- MMOXZBCLCQITDF-UHFFFAOYSA-N N,N-diethyl-m-toluamide Chemical compound CCN(CC)C(=O)C1=CC=CC(C)=C1 MMOXZBCLCQITDF-UHFFFAOYSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- NKSOSPOXQKNIKJ-CLFAGFIQSA-N Polyoxyethylene dioleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCCOC(=O)CCCCCCC\C=C/CCCCCCCC NKSOSPOXQKNIKJ-CLFAGFIQSA-N 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- CRKGMGQUHDNAPB-UHFFFAOYSA-N Sulconazole nitrate Chemical compound O[N+]([O-])=O.C1=CC(Cl)=CC=C1CSC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 CRKGMGQUHDNAPB-UHFFFAOYSA-N 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- IJCWFDPJFXGQBN-RYNSOKOISA-N [(2R)-2-[(2R,3R,4S)-4-hydroxy-3-octadecanoyloxyoxolan-2-yl]-2-octadecanoyloxyethyl] octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCCCCCCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCCCCCCCCCCCC IJCWFDPJFXGQBN-RYNSOKOISA-N 0.000 description 1
- CFTCNYXCIMEQQS-UHFFFAOYSA-N [3-(2,3-dihydroxypropoxy)-2-hydroxypropyl] decanoate Chemical compound CCCCCCCCCC(=O)OCC(O)COCC(O)CO CFTCNYXCIMEQQS-UHFFFAOYSA-N 0.000 description 1
- NPTLAYTZMHJJDP-KTKRTIGZSA-N [3-[3-[3-[3-[3-[3-[3-[3-[3-(2,3-dihydroxypropoxy)-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropyl] (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)CO NPTLAYTZMHJJDP-KTKRTIGZSA-N 0.000 description 1
- NEOSCXSMCDEQPS-UHFFFAOYSA-N [4-(2,2-dimethylpropanoyloxymethyl)-2-ethylhexyl] 2,2-dimethylpropanoate Chemical compound CC(C)(C)C(=O)OCC(CC)CC(CC)COC(=O)C(C)(C)C NEOSCXSMCDEQPS-UHFFFAOYSA-N 0.000 description 1
- ABKPAQVSXGDAOP-UHFFFAOYSA-N [5-(2,2-dimethylpropanoyloxy)-3-methylpentyl] 2,2-dimethylpropanoate Chemical compound CC(C)(C)C(=O)OCCC(C)CCOC(=O)C(C)(C)C ABKPAQVSXGDAOP-UHFFFAOYSA-N 0.000 description 1
- YFCGDEUVHLPRCZ-UHFFFAOYSA-N [dimethyl(trimethylsilyloxy)silyl]oxy-dimethyl-trimethylsilyloxysilane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C YFCGDEUVHLPRCZ-UHFFFAOYSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 150000003973 alkyl amines Chemical class 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- CBTVGIZVANVGBH-UHFFFAOYSA-N aminomethyl propanol Chemical compound CC(C)(N)CO CBTVGIZVANVGBH-UHFFFAOYSA-N 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 229960003121 arginine Drugs 0.000 description 1
- 235000009697 arginine Nutrition 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 229960005261 aspartic acid Drugs 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- XNEFYCZVKIDDMS-UHFFFAOYSA-N avobenzone Chemical compound C1=CC(OC)=CC=C1C(=O)CC(=O)C1=CC=C(C(C)(C)C)C=C1 XNEFYCZVKIDDMS-UHFFFAOYSA-N 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- 229960001950 benzethonium chloride Drugs 0.000 description 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
- 229960004217 benzyl alcohol Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- QRZAKQDHEVVFRX-UHFFFAOYSA-N biphenyl-4-ylacetic acid Chemical compound C1=CC(CC(=O)O)=CC=C1C1=CC=CC=C1 QRZAKQDHEVVFRX-UHFFFAOYSA-N 0.000 description 1
- HGKOWIQVWAQWDS-UHFFFAOYSA-N bis(16-methylheptadecyl) 2-hydroxybutanedioate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CC(O)C(=O)OCCCCCCCCCCCCCCCC(C)C HGKOWIQVWAQWDS-UHFFFAOYSA-N 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 239000010495 camellia oil Substances 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- SHZIWNPUGXLXDT-UHFFFAOYSA-N caproic acid ethyl ester Natural products CCCCCC(=O)OCC SHZIWNPUGXLXDT-UHFFFAOYSA-N 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229940056318 ceteth-20 Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 229940074979 cetyl palmitate Drugs 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 229960004022 clotrimazole Drugs 0.000 description 1
- VNFPBHJOKIVQEB-UHFFFAOYSA-N clotrimazole Chemical compound ClC1=CC=CC=C1C(N1C=NC=C1)(C=1C=CC=CC=1)C1=CC=CC=C1 VNFPBHJOKIVQEB-UHFFFAOYSA-N 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 229960005188 collagen Drugs 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 230000001877 deodorizing effect Effects 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- LVTYICIALWPMFW-UHFFFAOYSA-N diisopropanolamine Chemical compound CC(O)CNCC(C)O LVTYICIALWPMFW-UHFFFAOYSA-N 0.000 description 1
- 229940043276 diisopropanolamine Drugs 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- HXTCWLNZDIPLCA-UHFFFAOYSA-N dodecanoic acid;2-methylprop-2-enoic acid Chemical compound CC(=C)C(O)=O.CCCCCCCCCCCC(O)=O HXTCWLNZDIPLCA-UHFFFAOYSA-N 0.000 description 1
- GMSCBRSQMRDRCD-UHFFFAOYSA-N dodecyl 2-methylprop-2-enoate Chemical compound CCCCCCCCCCCCOC(=O)C(C)=C GMSCBRSQMRDRCD-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- OYFJQPXVCSSHAI-QFPUQLAESA-N enalapril maleate Chemical compound OC(=O)\C=C/C(O)=O.C([C@@H](C(=O)OCC)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(O)=O)CC1=CC=CC=C1 OYFJQPXVCSSHAI-QFPUQLAESA-N 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 229940093476 ethylene glycol Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 229960000192 felbinac Drugs 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000010492 gellan gum Nutrition 0.000 description 1
- 239000000216 gellan gum Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- 229940074050 glyceryl myristate Drugs 0.000 description 1
- 229940100608 glycol distearate Drugs 0.000 description 1
- 239000008169 grapeseed oil Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- PXDJXZJSCPSGGI-UHFFFAOYSA-N hexadecanoic acid hexadecyl ester Natural products CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC PXDJXZJSCPSGGI-UHFFFAOYSA-N 0.000 description 1
- OIKBVOIOVNEVJR-UHFFFAOYSA-N hexadecyl 6-methylheptanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCC(C)C OIKBVOIOVNEVJR-UHFFFAOYSA-N 0.000 description 1
- QICHMCRJUKQZRE-UHFFFAOYSA-N hexadecyl decanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCC QICHMCRJUKQZRE-UHFFFAOYSA-N 0.000 description 1
- OGEMCJNRDGZFQF-UHFFFAOYSA-N hexyl 2-benzoyl-4-(diethylamino)-3-hydroxybenzoate Chemical compound CCCCCCOC(=O)C1=CC=C(N(CC)CC)C(O)=C1C(=O)C1=CC=CC=C1 OGEMCJNRDGZFQF-UHFFFAOYSA-N 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 229940072106 hydroxystearate Drugs 0.000 description 1
- 230000000774 hypoallergenic effect Effects 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000000077 insect repellent Substances 0.000 description 1
- 229940100554 isononyl isononanoate Drugs 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- DKYWVDODHFEZIM-UHFFFAOYSA-N ketoprofen Chemical compound OC(=O)C(C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 DKYWVDODHFEZIM-UHFFFAOYSA-N 0.000 description 1
- 229960000991 ketoprofen Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 229940074358 magnesium ascorbate Drugs 0.000 description 1
- AIOKQVJVNPDJKA-ZZMNMWMASA-L magnesium;(2r)-2-[(1s)-1,2-dihydroxyethyl]-4-hydroxy-5-oxo-2h-furan-3-olate Chemical compound [Mg+2].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] AIOKQVJVNPDJKA-ZZMNMWMASA-L 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 235000006109 methionine Nutrition 0.000 description 1
- 229940095102 methyl benzoate Drugs 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 229960005040 miconazole nitrate Drugs 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- SLCVBVWXLSEKPL-UHFFFAOYSA-N neopentyl glycol Chemical compound OCC(C)(C)CO SLCVBVWXLSEKPL-UHFFFAOYSA-N 0.000 description 1
- 239000001272 nitrous oxide Substances 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- HMMGMWAXVFQUOA-UHFFFAOYSA-N octamethylcyclotetrasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 HMMGMWAXVFQUOA-UHFFFAOYSA-N 0.000 description 1
- CXQXSVUQTKDNFP-UHFFFAOYSA-N octamethyltrisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 description 1
- 229960001679 octinoxate Drugs 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- 229960001173 oxybenzone Drugs 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000003504 photosensitizing agent Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- 229920001592 potato starch Polymers 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 229940116422 propylene glycol dicaprate Drugs 0.000 description 1
- 229940010310 propylene glycol dioleate Drugs 0.000 description 1
- 229940071139 pyrrolidone carboxylate Drugs 0.000 description 1
- 230000001846 repelling effect Effects 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 description 1
- 235000010378 sodium ascorbate Nutrition 0.000 description 1
- 229960005055 sodium ascorbate Drugs 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 229960003885 sodium benzoate Drugs 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 235000011078 sorbitan tristearate Nutrition 0.000 description 1
- 239000001589 sorbitan tristearate Substances 0.000 description 1
- 229960004129 sorbitan tristearate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 229960004718 sulconazole nitrate Drugs 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- NJGWOFRZMQRKHT-UHFFFAOYSA-N surfactin Natural products CC(C)CCCCCCCCCC1CC(=O)NC(CCC(O)=O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CC(O)=O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)O1 NJGWOFRZMQRKHT-UHFFFAOYSA-N 0.000 description 1
- NJGWOFRZMQRKHT-WGVNQGGSSA-N surfactin C Chemical compound CC(C)CCCCCCCCC[C@@H]1CC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O1 NJGWOFRZMQRKHT-WGVNQGGSSA-N 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 125000000383 tetramethylene group Chemical group [H]C([H])([*:1])C([H])([H])C([H])([H])C([H])([H])[*:2] 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 125000003944 tolyl group Chemical group 0.000 description 1
- 150000005691 triesters Chemical class 0.000 description 1
- 229960004418 trolamine Drugs 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
Abstract
Description
本発明は、発泡性エアゾール組成物に関する。さらに詳しくは、油中水型エマルジョン原液と溶解性圧縮ガスとからなる発泡性エアゾール組成物に関する。 The present invention relates to a foamable aerosol composition. More specifically, the present invention relates to a foamable aerosol composition comprising a water-in-oil emulsion stock solution and a soluble compressed gas.
従来、化粧落としなどの用途に使用されるエアゾール組成物の場合、フォームなどの状態で適量を吐出した後に、化粧を落としたい部位(小鼻など)に付着させ、エアゾール組成物中の有効成分により化粧を落とす方法がとられている。その際、有効成分が充分に皮膚となじみ、皮脂や化粧成分などの油性成分を除去する性質が求められる。また、適用部位がたとえば顔の場合には、低刺激である必要がある。 Conventionally, in the case of aerosol compositions used for applications such as makeup removal, after an appropriate amount is ejected in the form of a foam, it is adhered to the site (such as the nose) where makeup is to be removed, and makeup is applied by the active ingredients in the aerosol composition. The method of dropping is taken. At that time, the active ingredient is sufficiently familiar with the skin, and the property of removing oily components such as sebum and cosmetic ingredients is required. In addition, when the application site is a face, for example, it is necessary to have low irritation.
たとえば特許文献1には、噴射剤として圧縮ガスを使用した人体用泡沫エアゾール組成物が開示されている。かかるエアゾール組成物によれば、クリーム状の水中油型エマルジョンを原液としており、適用したときに、環境温度に影響されることなく、安定かつ好適な泡沫を形成することができる。 For example, Patent Document 1 discloses a foam aerosol composition for a human body using compressed gas as a propellant. According to such an aerosol composition, a creamy oil-in-water emulsion is used as a stock solution, and when applied, a stable and suitable foam can be formed without being affected by the environmental temperature.
また特許文献2には、炭酸ガス、ポリグリセリン脂肪酸エステル、グリセリンを含有する発泡エアゾール剤形の水性洗顔化粧料が開示されている。この水性洗顔化粧料は泡沫として噴出し、泡沫は炭酸ガスを放出しつつミルク状に遷移し、この遷移過程で汚れを巻き込み、優れた洗浄効果を発揮する。また液化石油ガス(LPG)を配合していないため、LPGによるむずむず感を誘起せず、デリケートな肌にも好適である。 Patent Document 2 discloses an aqueous facial cleansing cosmetic in the form of a foamed aerosol containing carbon dioxide, polyglycerin fatty acid ester, and glycerin. This aqueous facial cleansing cosmetic is ejected as a foam, and the foam transitions to a milk state while releasing carbon dioxide gas. In this transition process, dirt is involved and an excellent cleaning effect is exhibited. Moreover, since it does not contain liquefied petroleum gas (LPG), it does not induce a feeling of itching due to LPG and is suitable for delicate skin.
特許文献3には、原液が油成分、水および親油性界面活性剤からなり、噴射剤がジメチルエーテルおよび炭酸ガスとからなるクリーム状の油中水型泡状エアゾール組成物が開示されている。かかるエアゾール組成物によれば、安定なエマルジョンを形成し、冷却感のあるクリーム状の泡沫をえることができる。また、この組成物は油中水型エマルジョンであるため、皮膚になじみやすく、また皮脂や化粧メイクを溶解して除去しやすくクレンジグ剤として優れた洗浄性が得られる。 Patent Document 3 discloses a creamy water-in-oil foam aerosol composition in which the stock solution is composed of an oil component, water and a lipophilic surfactant, and the propellant is composed of dimethyl ether and carbon dioxide. According to such an aerosol composition, a stable emulsion can be formed and a creamy foam having a cooling feeling can be obtained. In addition, since this composition is a water-in-oil emulsion, it is easy to adjust to the skin, and it is easy to dissolve and remove sebum and cosmetic makeup, thereby providing excellent cleansing properties as a cleansing agent.
しかしながら、特許文献1に記載の発明において、原液はクリーム状の水中油型エマルジョンであるため、皮膚になじみにくい、皮脂や化粧メイクなどの油性成分を除去する効果が弱いなどの問題がある。また、特許文献2に記載の発明も、HLBが12〜15程度のポリグリセリン脂肪酸エステルを使用していることから、原液は水中油型エマルジョンになり、特許文献1に記載の発明と同様に皮膚になじみにくい、皮脂や化粧メイクなどの油性成分を除去する効果が弱いなどの問題がある。さらに、特許文献3に記載の発明は、液化ガスであるジメチルエーテルを含有しているため、目の周りのように粘膜に近い箇所に使用すると刺激があるという問題がある。 However, in the invention described in Patent Document 1, since the stock solution is a cream-like oil-in-water emulsion, there are problems that it is difficult to adjust to the skin and the effect of removing oily components such as sebum and makeup makeup is weak. Moreover, since the invention described in Patent Document 2 also uses polyglycerin fatty acid ester having an HLB of about 12 to 15, the stock solution becomes an oil-in-water emulsion, and the skin as in the invention described in Patent Document 1 There are problems such as being unfamiliar and weak in removing oily components such as sebum and makeup. Furthermore, since the invention described in Patent Document 3 contains dimethyl ether, which is a liquefied gas, there is a problem that irritation occurs when it is used near a mucous membrane such as around the eyes.
本発明は上記問題に鑑みてなされたものであり、フォームが充分に皮膚となじみ、有効成分を皮膚に付着しやすくする、あるいは、皮脂や化粧成分などの油性成分を除去する性質を有し、かつ、適用部位がたとえば目の周りなどの粘膜に近い箇所にも使用できるよう低刺激である発泡性エアゾール組成物を得ることを目的とする。 The present invention has been made in view of the above problems, the foam is sufficiently familiar with the skin, makes the active ingredient easy to adhere to the skin, or has the property of removing oily components such as sebum and cosmetic ingredients, And it aims at obtaining the foamable aerosol composition which is low irritation so that an application site | part can be used also in the location close | similar to mucous membranes, such as the circumference | surroundings of eyes.
本発明の発泡性エアゾール組成物は、油性溶剤、乳化剤、発泡剤、水を含有し、前記乳化剤がHLB2〜7.5の親油性界面活性剤であり、油中水型エマルジョンを形成する原液と、溶解性圧縮ガスとからなる発泡性エアゾール組成物である。 The foamable aerosol composition of the present invention comprises an oily solvent, an emulsifier, a foaming agent, and water, the emulsifier is a lipophilic surfactant having an HLB of 2 to 7.5, and a stock solution that forms a water-in-oil emulsion. A foamable aerosol composition comprising a soluble compressed gas.
前記油性溶剤が原液中10〜85重量%、前記水が原液中5〜85重量%含まれてなることが好ましい。 It is preferable that 10 to 85% by weight of the oily solvent is contained in the stock solution and 5 to 85% by weight of the water is contained in the stock solution.
前記乳化剤が、ポリエチレングリコールジポリヒドロキシ脂肪酸エステル、ソルビタン脂肪酸エステル、ポリオキシエチレン硬化ヒマシ油から選ばれる少なくとも1種であることが好ましい。 The emulsifier is preferably at least one selected from polyethylene glycol dipolyhydroxy fatty acid ester, sorbitan fatty acid ester, and polyoxyethylene hydrogenated castor oil.
前記発泡剤が、ポリグリセリン脂肪酸エステル、ポリオキシエチレンソルビタン脂肪酸エステル、ポリオキシエチレンアルキルエーテル、ポリオキシエチレン硬化ヒマシ油、ポリエーテル変性シリコーンから選ばれる少なくとも1種であることが好ましい。 The foaming agent is preferably at least one selected from polyglycerin fatty acid ester, polyoxyethylene sorbitan fatty acid ester, polyoxyethylene alkyl ether, polyoxyethylene hydrogenated castor oil, and polyether-modified silicone.
前記乳化剤が原液中0.5〜10重量%含まれてなり、前記発泡剤が原液中0.1〜20重量%含まれてなることが好ましい。 The emulsifier is preferably contained in the stock solution in an amount of 0.5 to 10% by weight, and the foaming agent is preferably contained in the stock solution in an amount of 0.1 to 20% by weight.
前記圧縮ガスが炭酸ガスであることが好ましい。 The compressed gas is preferably carbon dioxide.
本発明の発泡性エアゾール組成物によれば、フォームが充分に皮膚となじみ、有効成分を皮膚に付着しやすく、皮脂や化粧成分などの油性成分を除去する性質を有し、かつ、適用部位がたとえば目の周りなどの粘膜に近い箇所にも使用できるよう低刺激である発泡性エアゾール組成物を得ることができる。 According to the foamable aerosol composition of the present invention, the foam is sufficiently familiar with the skin, the active ingredient is easily attached to the skin, has the property of removing oily components such as sebum and cosmetic ingredients, and the application site is For example, it is possible to obtain a foamable aerosol composition that is hypoallergenic so that it can also be used in places near the mucous membrane such as around the eyes.
本発明の発泡性エアゾール組成物は、油性溶剤、乳化剤、発泡剤、水を含有し、前記乳化剤がHLB2〜7.5の親油性界面活性剤であり、油中水型エマルジョンを形成する原液と、溶解性圧縮ガスとからなることを特徴とする。この発泡性エアゾール組成物は、原液が油中水型エマルジョンでありながら発泡してきめ細かなフォームを形成する。 The foamable aerosol composition of the present invention comprises an oily solvent, an emulsifier, a foaming agent, and water, the emulsifier is a lipophilic surfactant having an HLB of 2 to 7.5, and a stock solution that forms a water-in-oil emulsion. And a soluble compressed gas. This foamable aerosol composition foams to form a fine foam while the stock solution is a water-in-oil emulsion.
前記原液は、油性溶剤、乳化剤、発泡剤、水を含有し、油相中に水相が乳化した油中水型エマルジョンを形成する。 The stock solution contains an oily solvent, an emulsifier, a foaming agent, and water, and forms a water-in-oil emulsion in which the water phase is emulsified in the oil phase.
前記油性溶剤は油相の主成分となり、界面活性剤や有効成分などの溶剤として作用するとともに、フォームを皮膚になじみやすくする、皮脂や化粧メイクなどを除去する作用がある。 The oil-based solvent serves as a main component of the oil phase and acts as a solvent for surfactants, active ingredients, etc., and also has an action of removing sebum and cosmetic makeup, etc., making the foam easy to conform to the skin.
前記油性溶剤としては、たとえば、トリ(カプリル/カプリン酸)グリセリル、トリ2−エチルへキサン酸グリセリル、トリ(カプリル酸/カプリン酸/ステアリン酸)グリセリルなどのグリセリンと脂肪酸のトリエステル、ミリスチン酸イソプロピル、パルミチン酸イソプロピルなどの直鎖脂肪酸と低級アルコールのエステル、カプリン酸セチル、パルミチン酸セチル、イソノナン酸イソノニル、イソノナン酸イソトリデシルなどの高級脂肪酸と高級アルコールのエステル、モノカプリル酸プロピレングリコール、ジカプリル酸プロピレングリコール、ジカプリン酸プロピレングリコール、ステアリン酸プロピレングリコール、ジオレイン酸プロピレングリコールなどのプロピレングリコールと脂肪酸のモノおよびジエステル、ステアリン酸エチレングリコール、ジオレイン酸エチレングリコールなどのエチレングリコールと脂肪酸のモノおよびジエステル、イソオクタン酸セチル、ヒドロシキシステアリン酸オクチル、ヒドロシキシステアリン酸エチルヘキシルキシル、ジネオペンタン酸メチルペンタンジオール、ジネオペンタン酸ジエチルペンタンジオール、ジ−2−エチルへキサン酸ネオペンチルグリコール、ジカプリン酸ネオペンチルグリコール、メトキシケイヒ酸エチルヘキシル、コハク酸ジエトキシエチル、リンゴ酸ジイソステアリルなどのエステル油;オリーブ油、グレープシード油、ツバキ油、トウモロコシ油、ヒマシ油、サフラワー油、ホホバ油、ヤシ油などの油脂、流動パラフィン、軽質流動パラフィンなどの炭化水素、メチルポリシロキサン、カプリリルメチコン、オクタメチルシクロテトラシロキサン、デカメチルシクロペンタシロキサン、ドデカメチルシクロヘキサシロキサン、メチルシクロポリシロキサン、テトラヒドロテトラメチルシクロテトラシロキサン、オクタメチルトリシロキサン、デカメチルテトラシロキサン、メチルハイドロジェンポリシロキサン、メチルフェニルポリシロキサンなどのシリコーンオイル、オレイン酸などの高級脂肪酸、オレイルアルコール、イソステアリルアルコールなどの高級アルコールなど、常温(5〜35℃)で液状のものがあげられる。特に、発泡性に優れている点からエステル油、油脂、シリコーンオイルを用いることが好ましい。 Examples of the oily solvent include triesters of glycerin and fatty acid such as tri (capryl / capric acid) glyceryl, glyceryl tri-2-ethylhexanoate, tri (caprylic acid / capric acid / stearic acid) glyceryl, and isopropyl myristate. , Esters of linear fatty acids and lower alcohols such as isopropyl palmitate, esters of higher fatty acids and higher alcohols such as cetyl caprate, cetyl palmitate, isononyl isononanoate, isotridecyl isononanoate, propylene glycol monocaprylate, propylene glycol dicaprylate Mono- and diesters of propylene glycol and fatty acids, such as propylene glycol dicaprate, propylene glycol stearate, propylene glycol dioleate, stearic acid Mono- and diesters of ethylene glycol and fatty acids such as tylene glycol, ethylene glycol dioleate, cetyl isooctanoate, octyl hydroxystearate, ethylhexylxyl hydroxystearate, methylpentanediol dineopentanoate, diethylpentanediol dineopentanoate, di Ester oils such as neopentyl glycol 2-ethylhexanoate, neopentyl glycol dicaprate, ethylhexyl methoxycinnamate, diethoxyethyl succinate, diisostearyl malate; olive oil, grape seed oil, camellia oil, corn oil, Oils such as castor oil, safflower oil, jojoba oil, coconut oil, hydrocarbons such as liquid paraffin and light liquid paraffin, methylpolysiloxane, caprylyl methyl Con, octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, dodecamethylcyclohexasiloxane, methylcyclopolysiloxane, tetrahydrotetramethylcyclotetrasiloxane, octamethyltrisiloxane, decamethyltetrasiloxane, methylhydrogenpolysiloxane, methylphenyl Examples include silicone oils such as polysiloxane, higher fatty acids such as oleic acid, and higher alcohols such as oleyl alcohol and isostearyl alcohol, which are liquid at normal temperature (5-35 ° C.). In particular, it is preferable to use ester oils, fats, and silicone oils from the viewpoint of excellent foamability.
前記油性溶剤の配合量は、原液中10〜85重量%であることが好ましく、さらには15〜80重量%であることが好ましい。前記油性溶剤の配合量が10重量%よりも少ない場合は乳化しにくくなるという問題があり、85重量%よりも多い場合は発泡しにくくなるという問題がある。 The blending amount of the oily solvent is preferably 10 to 85% by weight in the stock solution, more preferably 15 to 80% by weight. When the amount of the oily solvent is less than 10% by weight, there is a problem that it is difficult to emulsify, and when it is more than 85% by weight, there is a problem that foaming becomes difficult.
前記乳化剤は、油相中に水相を乳化して油中水型エマルジョンを形成する。前記乳化剤はHLBが2〜7.5の親油性界面活性剤であり、HLBは3〜7であることが好ましい。HLBが2よりも小さい、または7.5よりも大きい場合は乳化しにくくなる。 The emulsifier emulsifies a water phase in an oil phase to form a water-in-oil emulsion. The emulsifier is a lipophilic surfactant having an HLB of 2 to 7.5, and the HLB is preferably 3 to 7. When HLB is smaller than 2 or larger than 7.5, it becomes difficult to emulsify.
前記乳化剤としては、たとえば、ジポリヒドロキシステアリン酸ポリエチレングリコール(EO:2〜40)などのポリエチレングリコールジポリヒドロキシ脂肪酸エステル、モノパルミチン酸ソルビタン、モノステアリン酸ソルビタン、モノオレイン酸ソルビタンなどのソルビタン脂肪酸エステル、POE硬化ヒマシ油(EO:5〜10)などのポリオキシエチレン硬化ヒマシ油、ジラウリン酸ポリエチレングリコール(EO:4〜12)、ジステアリン酸ポリエチレングリコール(EO:4〜12)、ジイソステアリン酸ポリエチレングリコール(EO:4〜12)、ジオレイン酸ポリエチレングリコール(EO:4〜12)、モノステアリン酸ポリエチレングリコール(EO:2〜5)、モノオレイン酸ポリエチレングリコール(EO:3〜6)、イソステアリン酸ポリエチレングリコール(EO:3〜6)などのポリエチレングリコール脂肪酸エステル、ミリスチン酸グリセリル、モノステアリン酸グリセリル、モノオレイン酸グリセリルなどのモノグリセリン脂肪酸エステルなどがあげられる。なお、EOは(OCH2CH2)、数字はn数を示す。 Examples of the emulsifier include polyethylene glycol dipolyhydroxy fatty acid esters such as polyethylene glycol dipolyhydroxystearate (EO: 2 to 40), sorbitan fatty acid esters such as sorbitan monopalmitate, sorbitan monostearate, and sorbitan monooleate. , Polyoxyethylene hydrogenated castor oil such as POE hydrogenated castor oil (EO: 5 to 10), polyethylene glycol dilaurate (EO: 4 to 12), polyethylene glycol distearate (EO: 4 to 12), polyethylene glycol diisostearate (EO) EO: 4 to 12), polyethylene glycol dioleate (EO: 4 to 12), polyethylene glycol monostearate (EO: 2 to 5), polyethylene glycol monooleate (EO) 3-6), isostearic acid polyethylene glycol (EO: 3-6) Polyethylene glycol fatty acid esters such as myristic acid, glyceryl monostearate, etc. monoglycerol fatty acid esters such as glyceryl monooleate and the like. Note that EO represents (OCH 2 CH 2 ), and the number represents the number n.
前記乳化剤の中でも乳化安定性に優れている点からポリエチレングリコールジポリヒドロキシ脂肪酸エステル、ソルビタン脂肪酸エステル、ポリオキシエチレン硬化ヒマシ油を用いることが好ましく、特にポリエチレングリコールジポリヒドロキシ脂肪酸エステルを用いることが好ましい。 Among the emulsifiers, polyethylene glycol dipolyhydroxy fatty acid ester, sorbitan fatty acid ester, polyoxyethylene hydrogenated castor oil is preferably used, and polyethylene glycol dipolyhydroxy fatty acid ester is particularly preferably used because of its excellent emulsion stability. .
前記乳化剤の配合量は、原液中0.5〜10重量%であることが好ましく、さらには1〜8重量%であることが好ましい。前記乳化剤の配合量が0.5重量%よりも少ない場合は油中水型エマルジョンを形成しにくくなるという問題があり、10重量%よりも多い場合は使用後皮膚に残りやすくなるという問題がある。 The amount of the emulsifier is preferably 0.5 to 10% by weight in the stock solution, more preferably 1 to 8% by weight. When the amount of the emulsifier is less than 0.5% by weight, there is a problem that it is difficult to form a water-in-oil emulsion, and when it is more than 10% by weight, it tends to remain on the skin after use. .
前記発泡剤は、エアゾール組成物を外部に吐出したときに原液中に溶解している溶解性圧縮ガスの揮発により油中水型エマルジョン原液を発泡させる。 The foaming agent foams a water-in-oil emulsion stock solution by volatilization of a soluble compressed gas dissolved in the stock solution when the aerosol composition is discharged to the outside.
前記発泡剤としては、たとえば、モノラウリン酸ジグリセリル、モノカプリン酸ジグリセリル、モノラウリン酸ペンタグリセリル、モノミリスチン酸ペンタグリセリル、モノオレイン酸ペンタグリセリル、モノステアリン酸ペンタグリセリル、モノイソステアリン酸ペンタグリセリル、カプリル酸ヘキサグリセリル、モノラウリン酸ヘキサグリセリル、モノミリスチン酸ヘキサグリセリル、モノステアリン酸ヘキサグリセリル、モノオレイン酸ヘキサグリセリル、モノカプリン酸デカグリセリル、モノラウリン酸デカグリセリル、モノミリスチン酸デカグリセリル、モノオレイン酸デカグリセリル、モノステアリン酸デカグリセリル、ジステアリン酸デカグリセリルなどのポリグリセリン脂肪酸エステル、モノヤシ油脂肪酸POEソルビタン(EO:20)、モノパルミチン酸POEソルビタン(EO:6〜20)、モノステアリン酸POEソルビタン(EO:6)、トリステアリン酸POEソルビタン(EO:20)、モノオレイン酸POEソルビタン(EO:6〜20)などのポリオキシエチレンソルビタン脂肪酸エステル、POEラウリルエーテル(EO:2〜9)、POEセチルエーテル(EO:2〜10)、POEステアリルエーテル(EO:2〜10)、POEオレイルエーテル(EO:2〜10)などのポリオキシエチレンアルキルエーテル、POE硬化ヒマシ油(EO:20〜80)などのポリオキシエチレン硬化ヒマシ油、モノステアリン酸POEグリセリル(EO:5〜15)、モノオレイン酸POEグリセリル(EO:5〜15)などのポリオキシエチレングリセリン脂肪酸エステル、ポリ(POE・POP)ブチレン・メチルポリシロキサン共重合体、POE・メチルポリシロキサン共重合体、ポリ(POE・POP)・メチルポリシロキサン共重合体などのポリエーテル変性シリコーンなどがあげられる。なお、EOは(OCH2CH2)、数字はn数を示す。 Examples of the foaming agent include diglyceryl monolaurate, diglyceryl monocaprate, pentaglyceryl monolaurate, pentaglyceryl monomyristate, pentaglyceryl monooleate, pentaglyceryl monostearate, pentaglyceryl monoisostearate, caprylic acid Hexaglyceryl, hexaglyceryl monolaurate, hexaglyceryl monomyristate, hexaglyceryl monostearate, hexaglyceryl monooleate, decaglyceryl monocaprate, decaglyceryl monolaurate, decaglyceryl monomyristate, decaglyceryl monooleate, mono Polyglyceryl fatty acid esters such as decaglyceryl stearate and decaglyceryl distearate, monococonut oil fatty acid POE sorbitan EO: 20), POE sorbitan monopalmitate (EO: 6-20), POE sorbitan monostearate (EO: 6), POE sorbitan tristearate (EO: 20), POE sorbitan monooleate (EO: 6- 20) polyoxyethylene sorbitan fatty acid ester, POE lauryl ether (EO: 2 to 9), POE cetyl ether (EO: 2 to 10), POE stearyl ether (EO: 2 to 10), POE oleyl ether (EO: 2-10) polyoxyethylene alkyl ether, POE hydrogenated castor oil (EO: 20-80), etc., polyoxyethylene hydrogenated castor oil, POE glyceryl monostearate (EO: 5-15), POE glyceryl monooleate Polyoxyethylene such as (EO: 5-15) Examples include polyether-modified silicone such as lysine fatty acid ester, poly (POE / POP) butylene / methylpolysiloxane copolymer, POE / methylpolysiloxane copolymer, and poly (POE / POP) / methylpolysiloxane copolymer. It is done. Note that EO represents (OCH 2 CH 2 ), and the number represents the number n.
前記発泡剤の中でも、発泡性に優れる点から、ポリグリセリン脂肪酸エステル、ポリオキシエチレンソルビタン脂肪酸エステル、ポリオキシエチレンアルキルエーテル、ポリオキシエチレン硬化ヒマシ油などのHLBが7.5〜16である親水性非イオン式界面活性剤、HLBが1〜8であるポリエーテル変性シリコーンを用いることが好ましく、特にポリグリセリン脂肪酸エステル、ポリエーテル変性シリコーンが好ましい。 Among the foaming agents, from the viewpoint of excellent foamability, hydrophilicity such as polyglycerin fatty acid ester, polyoxyethylene sorbitan fatty acid ester, polyoxyethylene alkyl ether, polyoxyethylene hydrogenated castor oil, and HLB of 7.5-16 It is preferable to use a nonionic surfactant and a polyether-modified silicone having an HLB of 1 to 8, and polyglycerin fatty acid ester and polyether-modified silicone are particularly preferable.
前記発泡剤の配合量は、原液中0.1〜20重量%であることが好ましく、さらには0.3〜15重量%であることが好ましい。前記発泡剤の配合量が0.1重量%よりも少ない場合は発泡しにくくなるという問題があり、20重量%よりも多い場合は使用後皮膚に残りやすくなるという問題がある。 The blending amount of the foaming agent is preferably 0.1 to 20% by weight in the stock solution, more preferably 0.3 to 15% by weight. When the blending amount of the foaming agent is less than 0.1% by weight, there is a problem that foaming is difficult, and when the blending amount is more than 20% by weight, there is a problem that it tends to remain on the skin after use.
前記水は水相の主成分であり、油相内に分散し、溶解した圧縮ガスにより油中水型エマルジョン原液を発泡させる。 The water is the main component of the water phase, and is dispersed in the oil phase, and the water-in-oil emulsion stock solution is foamed by the dissolved compressed gas.
前記水は精製水、イオン交換水などを用いることができ、配合量は原液中5〜85重量%、さらには10〜80重量%であることが好ましい。水の配合量が5重量%よりも少ない場合は発泡しにくくなるという問題があり、85重量%よりも多い場合は油中水型エマルジョンが不安定になりやすいという問題がある。 As the water, purified water, ion-exchanged water or the like can be used, and the blending amount is preferably 5 to 85% by weight, more preferably 10 to 80% by weight in the stock solution. When the amount of water is less than 5% by weight, there is a problem that foaming is difficult, and when it is more than 85% by weight, there is a problem that the water-in-oil emulsion tends to become unstable.
なお、原液には、前記油性溶剤、発泡剤、乳化剤、水以外にも、用途や目的に応じて有効成分、他の界面活性剤、アルコール類、水溶性高分子、パウダーなどを配合することができる。 In addition to the oily solvent, foaming agent, emulsifier and water, the stock solution may contain active ingredients, other surfactants, alcohols, water-soluble polymers, powders, etc. depending on the purpose and purpose. it can.
前記有効成分としては、たとえば、パラメトキシケイ皮酸エチルヘキシル、パラメトキシケイ皮酸イソプロピル、パラメトキシケイ皮酸オクチル、ジメトキシベンジリデンジオキソイミダゾリジンプロピオン酸オクチル、ジエチルアミノヒドロキシベンゾイル安息香酸ヘキシル、エチルヘキシルトリアゾン、オクトクレリン、オキシベンゾン、ヒドロキシベンゾフェノンスルホン酸、ジヒドロキシベンゾフェノンスルホン酸ナトリウム、ジヒドロキシベンゾフェノン、パラアミノ安息香酸などの紫外線吸収剤、N,N−ジエチル−m−トルアミド(ディート)などの害虫忌避剤、α−トコフェロール、ジブチルヒドロキシトルエンなどの酸化防止剤、レチノール、dl−α−トコフェロールなどのビタミン類、グリチルレチン酸などの抗炎症剤、硝酸ミコナゾール、硝酸スルコナゾール、クロトリマゾールなどの抗真菌剤、サリチル酸メチル、インドメタシン、フェルビナク、ケトプロフェンなどの消炎鎮痛剤、l−メントール、カンフルなどの清涼化剤、ラウリルメタクリレート、ゲラニルクロトレート、ミリスチン酸アセトフェノン、酢酸ベンジル、プロピオン酸ベンジル、フェニル酢酸メチルなどの消臭成分、エチレングリコール、プロピレングリコール、グリセリン、1,3−ブチレングリコール、コラーゲン、キシリトール、ソルビトール、ヒアルロン酸、カロニン酸、乳酸ナトリウム、dl−ピロリドンカルボン酸塩、ケラチン、カゼイン、レシチン、尿素などの保湿剤、パラオキシ安息香酸エステル、安息香酸ナトリウム、ソルビン酸カリウム、フェノキシエタノール、塩化ベンザルコニウム、塩化ベンゼトニウム、塩化クロルヘキシジン、感光素、パラクロルメタクレゾールなどの殺菌消毒剤;ラウリル酸メタクリレート、安息香酸メチル、フェニル酢酸メチル、ゲラニルクロトレート、ミリスチン酸アセトフェノン、酢酸ベンジル、プロピオン酸ベンジルなどの消臭剤、グリシン、アラニン、ロイシン、セリン、トリプトファン、シスチン、システイン、メチオニン、アスパラギン酸、グルタミン酸、アルギニンなどのアミノ酸、パントテン酸カルシウム、アスコルビン酸リン酸マグネシウム、アスコルビン酸ナトリウムなどのビタミン類、香料などがあげられ、溶解性に応じて油相および/または水相に配合することができる。 Examples of the active ingredient include ethylhexyl paramethoxycinnamate, isopropyl paramethoxycinnamate, octyl paramethoxycinnamate, octyl dimethoxybenzylidene dioxoimidazolidine propionate, hexyl diethylaminohydroxybenzoylbenzoate, ethylhexyltriazone, UV absorbers such as octoclerin, oxybenzone, hydroxybenzophenone sulfonic acid, sodium dihydroxybenzophenone sulfonate, dihydroxybenzophenone, paraaminobenzoic acid, insect repellents such as N, N-diethyl-m-toluamide (diet), α-tocopherol, dibutyl Anti-inflammatory agents such as antioxidants such as hydroxytoluene, vitamins such as retinol and dl-α-tocopherol, and glycyrrhetinic acid , Antifungal agents such as miconazole nitrate, sulconazole nitrate, clotrimazole, anti-inflammatory agents such as methyl salicylate, indomethacin, felbinac, ketoprofen, cooling agents such as l-menthol, camphor, lauryl methacrylate, geranyl crolate, myristic acid Deodorizing ingredients such as acetophenone, benzyl acetate, benzyl propionate, methyl phenylacetate, ethylene glycol, propylene glycol, glycerin, 1,3-butylene glycol, collagen, xylitol, sorbitol, hyaluronic acid, caronic acid, sodium lactate, dl- Moisturizers such as pyrrolidone carboxylate, keratin, casein, lecithin, urea, paraoxybenzoate, sodium benzoate, potassium sorbate, phenoxyethanol Bactericides and disinfectants such as benzalkonium chloride, benzethonium chloride, chlorhexidine chloride, photosensitizer, parachlormethcresol; lauric acid methacrylate, methyl benzoate, methyl phenylacetate, geranyl crotolate, acetophenone myristate, benzyl acetate, benzyl propionate Deodorants such as glycine, alanine, leucine, serine, tryptophan, cystine, cysteine, methionine, amino acids such as aspartic acid, glutamic acid, arginine, vitamins such as calcium pantothenate, magnesium ascorbate phosphate, sodium ascorbate, A fragrance | flavor etc. are mention | raise | lifted and it can mix | blend with an oil phase and / or a water phase according to solubility.
前記有効成分は溶解性に応じて油相、水相いずれに配合してもよく、その配合量は、原液中0.01〜20重量%であることが好ましく、さらには0.05〜10重量%であることが好ましい。前記有効成分の配合量が0.01重量%よりも少ない場合は皮膚に付着する量が少なく、有効成分の効果が不充分になりやすいという問題があり、20重量%よりも多い場合は均一に塗布しにくくなり、配合量に対する効果が不充分になるという問題がある。 The active ingredient may be blended in either the oil phase or the aqueous phase depending on the solubility, and the blending amount is preferably 0.01 to 20% by weight, more preferably 0.05 to 10% by weight in the stock solution. % Is preferred. When the amount of the active ingredient is less than 0.01% by weight, there is a problem that the amount attached to the skin is small and the effect of the active ingredient tends to be insufficient, and when the amount is more than 20% by weight, it is uniform. There exists a problem that it becomes difficult to apply | coat and the effect with respect to a compounding quantity becomes inadequate.
前記他の界面活性剤は、乳化安定性、発泡性、皮膚へのなじみ、洗浄性を補助するなどの目的で用いられる。 The other surfactants are used for the purpose of assisting in emulsion stability, foamability, familiarity with the skin and cleanability.
前記他の界面活性剤としては、たとえば、ポリオキシエチレンアルキルエーテルリン酸およびその塩などのアニオン系界面活性剤、ポリオキシエチレンアルキルアミン、サーファクチンナトリウムなどのアニオン系界面活性剤、N−ヤシ油脂肪酸アシル−L−グルタミン酸トリエタノールアミンなどのアミノ酸系界面活性剤などがあげられる。 Examples of the other surfactants include anionic surfactants such as polyoxyethylene alkyl ether phosphoric acid and salts thereof, anionic surfactants such as polyoxyethylene alkylamine and surfactin sodium, and N-coconut oil. And amino acid surfactants such as fatty acyl-L-glutamic acid triethanolamine.
前記他の界面活性剤は溶解性に応じて油相、水相いずれに配合してもよく、その配合量は、原液中0.1〜10重量%であることが好ましく、さらには0.5〜5重量%であることが好ましい。前記他の界面活性剤の配合量が0.1重量%よりも少ない場合は配合効果が得られにくいという問題があり、10重量%よりも多い場合は使用後皮膚に残りやすいという問題がある。 The other surfactant may be blended in either the oil phase or the water phase depending on the solubility, and the blending amount is preferably 0.1 to 10% by weight in the stock solution, more preferably 0.5 It is preferably ˜5% by weight. When the amount of the other surfactant is less than 0.1% by weight, there is a problem that it is difficult to obtain a blending effect, and when it is more than 10% by weight, there is a problem that it tends to remain on the skin after use.
前記アルコール類は、圧縮ガスの溶解量を多くして発泡しやすくする、水相の乾燥を調整するなどの目的で用いられ、たとえば、エタノール、イソプロピルアルコールなどの炭素数が2〜3個の1価アルコール、プロピレングリコール、1,3−ブチレングリコール、グリセリンなどの炭素数が3〜5個の2〜3価アルコールなどがあげられる。 The alcohols are used for the purpose of increasing the dissolved amount of the compressed gas to facilitate foaming and adjusting the drying of the aqueous phase. For example, ethanol, isopropyl alcohol and the like having 2 to 3 carbon atoms are used. Examples thereof include 2- to 3-hydric alcohols having 3 to 5 carbon atoms such as monohydric alcohol, propylene glycol, 1,3-butylene glycol and glycerin.
前記アルコール類は油相、水相いずれに配合してもよく、その配合量は、原液中0.1〜20重量%、さらには0.5〜10重量%であることが好ましい。前記アルコール類の配合量が0.1重量%よりも少ない場合は配合効果が得られにくいという問題があり、20重量%よりも多い場合はエマルジョンの安定性が低下しやすく、発泡しにくくなるという問題がある。 The alcohols may be blended in either the oil phase or the aqueous phase, and the blending amount is preferably 0.1 to 20% by weight, more preferably 0.5 to 10% by weight in the stock solution. When the amount of the alcohol is less than 0.1% by weight, there is a problem that the blending effect is difficult to obtain, and when it is more than 20% by weight, the stability of the emulsion is likely to be lowered and foaming is difficult. There's a problem.
前記水溶性高分子は、水相の粘度を高くしてエマルジョンを安定化させるなどの目的で用いられる。 The water-soluble polymer is used for the purpose of stabilizing the emulsion by increasing the viscosity of the aqueous phase.
前記水溶性高分子としては、たとえば、ヒドロキシエチルセルロース、ヒドロキシプロピルセルロース、カルボキシメチルセルロース、ニトルセルロース、メチルセルロース、エチルセルロースなどのセルロース類、キサンタンガム、ジェランガム、カラギーナン、グアガムなどのガム類、デキストリン、ペクチン、デンプン、ゼラチン、ゼラチン加水分解物、アルギン酸ナトリウム、変性ポテトスターチ、ポリビニルアルコール、ポリビニルピロリドン、カルボキシビニルポリマー、(アクリレーツ/イタコン酸ステアレス−20)コポリマー、(アクリレーツ/イタコン酸セテス−20)コポリマーなどのアクリル酸エステルなどがあげられる。 Examples of the water-soluble polymer include celluloses such as hydroxyethyl cellulose, hydroxypropyl cellulose, carboxymethyl cellulose, nitrulose cellulose, methyl cellulose, ethyl cellulose, gums such as xanthan gum, gellan gum, carrageenan, guar gum, dextrin, pectin, starch, gelatin , Gelatin hydrolyzate, sodium alginate, modified potato starch, polyvinyl alcohol, polyvinylpyrrolidone, carboxyvinyl polymer, (acrylates / stearonic acid-20 steareth-20) copolymer, acrylic esters such as (acrylates / cetaconic acid ceteth-20) copolymer, etc. Can be given.
前記水溶性高分子の配合量は、原液中0.01〜3重量%、さらには0.05〜2重量%であることが好ましい。水溶性高分子の配合量が0.01重量%よりも少ない場合は前述の効果が得られにくいという問題があり、3重量%よりも多い場合は水相の粘度が高くなりすぎ、油相と混ざりにくく乳化が困難になるという問題がある。 The blending amount of the water-soluble polymer is preferably 0.01 to 3% by weight, more preferably 0.05 to 2% by weight in the stock solution. When the blending amount of the water-soluble polymer is less than 0.01% by weight, there is a problem that the above-mentioned effect is difficult to obtain. When the blending amount is more than 3% by weight, the viscosity of the aqueous phase becomes too high, There is a problem that it is difficult to mix and emulsification becomes difficult.
なお、カルボキシビニルポリマー、(アクリレーツ/イタコン酸ステアレス−20)コポリマー、(アクリレーツ/イタコン酸セテス−20)コポリマーなどの会合型高分子を用いる場合は水相のpHを調整するpH調整剤を用いることが好ましい。前記pH調整剤としては、トリエタノールアミン、ジイソプロパノールアミン、2−アミノ−2−メチル−1−プロパノール、2−アミノ−2−メチル−1、3−プロパンジオールなどの有機アルカリ、水酸化ナトリウム、水酸化カリウム、水酸化アンモニウムなどの無機アルカリなどがあげられ、これらpH調整剤を用いて水相のpHを6〜9に調整し、粘度を高くする。 In addition, when using an associative polymer such as a carboxyvinyl polymer, an (acrelate / itaconate steareth-20) copolymer, an (acrelate / itaconate seteth-20) copolymer, a pH adjuster that adjusts the pH of the aqueous phase is used. Is preferred. Examples of the pH adjusting agent include triethanolamine, diisopropanolamine, 2-amino-2-methyl-1-propanol, 2-amino-2-methyl-1, 3-propanediol and other organic alkalis, sodium hydroxide, Examples thereof include inorganic alkalis such as potassium hydroxide and ammonium hydroxide, and the pH of the aqueous phase is adjusted to 6 to 9 using these pH adjusters to increase the viscosity.
前記パウダーは原液中では分散しており、エマルジョンの安定性を良くする、皮膚に塗布されると紫外線を散乱させる紫外線散乱剤として作用したり、水や汗をはじき皮膚に長く付着して日焼けを長時間防止する、またべたつきを抑え使用感を良くするなどの効果を有する。 The powder is dispersed in the undiluted solution, improving the stability of the emulsion, acting as an ultraviolet scattering agent that scatters ultraviolet rays when applied to the skin, or sticking to the skin for a long time by repelling water and sweat and sunburning. It has effects such as prevention for a long time and suppression of stickiness to improve usability.
前記パウダーとしては、たとえば、酸化亜鉛、酸化チタン、タルク、セリサイト、シリカ、ナイロンパウダーなどがあげられる。 Examples of the powder include zinc oxide, titanium oxide, talc, sericite, silica, and nylon powder.
前記パウダーの配合量は、原液中0.1〜10重量%、さらには0.5〜8重量%であることが好ましい。配合量が0.1重量%よりも少ない場合はパウダーの効果が得られにくいという問題があり、10重量%よりも多い場合はパウダー濃度が高くなりすぎて均一に塗布しにくく、白くなりやすいという問題がある。 The blending amount of the powder is preferably 0.1 to 10% by weight, more preferably 0.5 to 8% by weight in the stock solution. When the blending amount is less than 0.1% by weight, there is a problem that it is difficult to obtain the effect of the powder. When the blending amount is more than 10% by weight, the powder concentration becomes too high to be applied uniformly and is likely to become white. There's a problem.
前記原液は、たとえば、乳化剤(親油性界面活性剤)を油性溶剤に配合して油相を調製し、油相とは別に調整した水相を油相に添加して混合することにより油中水型エマルジョン原液を調整することができる。なお、油相の一部に水相を添加して油中水型エマルジョンを形成し、後で油相の残りを添加してもよい。 The stock solution is prepared by, for example, blending an emulsifier (lipophilic surfactant) in an oily solvent to prepare an oil phase, and adding an aqueous phase prepared separately from the oil phase to the oil phase and mixing the water in oil. Type emulsion stock solution can be adjusted. The water phase may be added to a part of the oil phase to form a water-in-oil emulsion, and the remainder of the oil phase may be added later.
前記油相と水相の重量比は、油相/水相=90/10〜10/90であることが好ましく、さらには85/15〜15/85であることが好ましい。前記重量比が90/10よりも大きい場合、すなわち水相が少ない場合は発泡しにくくなるという問題があり、10/90よりも小さい場合、すなわち水相が多い場合は油中水型エマルジョンが不安定になりやすいという問題がある。 The weight ratio of the oil phase to the water phase is preferably oil phase / water phase = 90/10 to 10/90, and more preferably 85/15 to 15/85. When the weight ratio is larger than 90/10, that is, when the aqueous phase is small, there is a problem that foaming is difficult. When it is smaller than 10/90, that is, when the aqueous phase is large, the water-in-oil emulsion is not suitable. There is a problem that it tends to be stable.
本発明の発泡性エアゾール組成物は、前記油中水型エマルジョン原液を耐圧性の容器に充填し、容器の開口部にエアゾールバルブを固着、圧縮ガスを充填することにより調製することができる。 The foamable aerosol composition of the present invention can be prepared by filling the water-in-oil emulsion stock solution in a pressure-resistant container, fixing an aerosol valve to the opening of the container, and filling a compressed gas.
前記溶解性圧縮ガスは、エアゾール容器内では原液の油相と水相いずれにも溶解するが、大気中に吐出されると内相の水相に溶解した圧縮ガスが気化して油中水型エマルジョン原液を発泡させる。前記溶解性圧縮ガスとしては、25℃における水への溶解度が0.3以上であるものを用いることが好ましく、たとえば、炭酸ガス(0.759ml/ml)、亜酸化窒素ガス(0.575ml/ml)、およびこれらの混合物などがあげられる。溶解度が0.3よりも小さい場合は発泡しにくくなる。 The soluble compressed gas dissolves in both the oil phase and the aqueous phase of the stock solution in the aerosol container, but when discharged into the atmosphere, the compressed gas dissolved in the aqueous phase of the internal phase is vaporized to form a water-in-oil type. Foam the emulsion stock solution. As the soluble compressed gas, those having a solubility in water at 25 ° C. of 0.3 or more are preferably used. For example, carbon dioxide gas (0.759 ml / ml), nitrous oxide gas (0.575 ml / ml) ml), and mixtures thereof. When the solubility is less than 0.3, foaming is difficult.
前記溶解性圧縮ガスにより、容器内の圧力を0.4〜1.0MPa、さらには0.5〜0.9MPa(25℃)にすることが好ましい。圧力が0.4MPaよりも小さい場合は発泡が小さくなりやすいという問題があり、1.0MPaよりも大きい場合は吐出時の勢いが強くなり飛び散りやすくなるという問題がある。 The pressure in the container is preferably 0.4 to 1.0 MPa, more preferably 0.5 to 0.9 MPa (25 ° C.) with the soluble compressed gas. When the pressure is less than 0.4 MPa, there is a problem that foaming tends to be small, and when the pressure is more than 1.0 MPa, there is a problem that the momentum at the time of discharge becomes strong and it tends to scatter.
以下、実施例により、本発明の発泡性エアゾール組成物をより詳細に説明するが、本発明は、なんらこれらに限定されるものではない。 Hereinafter, although the foamable aerosol composition of this invention is demonstrated in detail by an Example, this invention is not limited to these at all.
実施例1
表1に示す油相1、油相2、水相をそれぞれ調製し、水相を油相1に添加して攪拌した。さらに油相2を添加して攪拌し、油中水型エマルジョン原液1を調製した。この原液1をアルミニウム性耐圧容器に100g充填し、エアゾールバルブを取り付け、容器内の圧力が0.6MPa(25℃)となるように炭酸ガスを充填し、発泡性エアゾール組成物を製造した。
Example 1
The oil phase 1, the oil phase 2, and the water phase shown in Table 1 were prepared, and the water phase was added to the oil phase 1 and stirred. Further, oil phase 2 was added and stirred to prepare water-in-oil emulsion stock solution 1. 100 g of this stock solution 1 was filled in an aluminum pressure-resistant container, an aerosol valve was attached, and carbon dioxide gas was filled so that the pressure in the container was 0.6 MPa (25 ° C.) to produce a foamable aerosol composition.
実施例2
原液2を用いたこと以外は実施例1と同様にして発泡性エアゾール組成物を製造した。
Example 2
A foamable aerosol composition was produced in the same manner as in Example 1 except that the stock solution 2 was used.
実施例3
原液3を用いたこと以外は実施例1と同様にして発泡性エアゾール組成物を製造した。
Example 3
A foamable aerosol composition was produced in the same manner as in Example 1 except that the stock solution 3 was used.
実施例4
原液4を用いたこと以外は実施例1と同様にして発泡性エアゾール組成物を製造した。
Example 4
A foamable aerosol composition was produced in the same manner as in Example 1 except that the stock solution 4 was used.
実施例5
原液5を用いたこと以外は実施例1と同様にして発泡性エアゾール組成物を製造した。
Example 5
A foamable aerosol composition was produced in the same manner as in Example 1 except that the stock solution 5 was used.
実施例6
表2に原液6を用いたこと以外は実施例1と同様にして発泡性エアゾール組成物を製造した。
Example 6
A foamable aerosol composition was produced in the same manner as in Example 1 except that the stock solution 6 was used in Table 2.
実施例7
原液7を用いたこと以外は実施例1と同様にして発泡性エアゾール組成物を製造した。
Example 7
A foamable aerosol composition was produced in the same manner as in Example 1 except that the stock solution 7 was used.
実施例8
原液8を用いたこと以外は実施例1と同様にして発泡性エアゾール組成物を製造した。
Example 8
A foamable aerosol composition was produced in the same manner as in Example 1 except that the stock solution 8 was used.
実施例9
原液9を用いたこと以外は実施例1と同様にして発泡性エアゾール組成物を製造した。
Example 9
A foamable aerosol composition was produced in the same manner as in Example 1 except that the stock solution 9 was used.
実施例10
原液10を用いたこと以外は実施例1と同様にして発泡性エアゾール組成物を製造した。
Example 10
A foamable aerosol composition was produced in the same manner as in Example 1 except that the stock solution 10 was used.
実施例11
表3に示す油相、水相をそれぞれ調製し、水相を油相に添加して攪拌し、油中水型エマルジョン原液11を調製した。この原液11をアルミニウム性耐圧容器に100g充填し、エアゾールバルブを取り付け、容器内の圧力が0.6MPa(25℃)となるように炭酸ガスを充填し、発泡性エアゾール組成物を製造した。
Example 11
An oil phase and an aqueous phase shown in Table 3 were prepared, and the aqueous phase was added to the oil phase and stirred to prepare a water-in-oil emulsion stock solution 11. 100 g of this stock solution 11 was filled in an aluminum pressure-resistant container, an aerosol valve was attached, and carbon dioxide gas was filled so that the pressure in the container was 0.6 MPa (25 ° C.) to produce a foamable aerosol composition.
実施例12
原液12を用いたこと以外は実施例11と同様にして発泡性エアゾール組成物を製造した。
Example 12
A foamable aerosol composition was produced in the same manner as in Example 11 except that the stock solution 12 was used.
実施例13
原液13を用いたこと以外は実施例11と同様にして発泡性エアゾール組成物を製造した。
Example 13
A foamable aerosol composition was produced in the same manner as in Example 11 except that the stock solution 13 was used.
実施例14
原液14を用いたこと以外は実施例11と同様にして発泡性エアゾール組成物を製造した。
Example 14
A foamable aerosol composition was produced in the same manner as in Example 11 except that the stock solution 14 was used.
実施例15
原液15を用いたこと以外は実施例11と同様にして発泡性エアゾール組成物を製造した。
Example 15
A foamable aerosol composition was produced in the same manner as in Example 11 except that the stock solution 15 was used.
実施例16
表4に示す油相、水相をそれぞれ調製し、水相を油相に添加して攪拌し、油中水型エマルジョン原液16を調製した。この原液16をアルミニウム性耐圧容器に100g充填し、エアゾールバルブを取り付け、容器内の圧力が0.6MPa(25℃)となるように炭酸ガスを充填し、発泡性エアゾール組成物を製造した。
Example 16
An oil phase and an aqueous phase shown in Table 4 were prepared, and the aqueous phase was added to the oil phase and stirred to prepare a water-in-oil emulsion stock solution 16. 100 g of this stock solution 16 was filled in an aluminum pressure-resistant container, an aerosol valve was attached, and carbon dioxide gas was filled so that the pressure in the container was 0.6 MPa (25 ° C.) to produce a foamable aerosol composition.
実施例17
原液17を用いたこと以外は実施例16と同様にして発泡性エアゾール組成物を製造した。
Example 17
A foamable aerosol composition was produced in the same manner as in Example 16 except that the stock solution 17 was used.
実施例18
原液18を用いたこと以外は実施例16と同様にして発泡性エアゾール組成物を製造した。
Example 18
A foamable aerosol composition was produced in the same manner as in Example 16 except that the stock solution 18 was used.
実施例19
原液19を用いたこと以外は実施例16と同様にして発泡性エアゾール組成物を製造した。
Example 19
A foamable aerosol composition was produced in the same manner as in Example 16 except that the stock solution 19 was used.
実施例20
原液20を用いたこと以外は実施例16と同様にして発泡性エアゾール組成物を製造した。
Example 20
A foamable aerosol composition was produced in the same manner as in Example 16 except that the stock solution 20 was used.
実施例21
表5に示す油相、水相をそれぞれ調製し、水相を油相に添加して攪拌し、油中水型エマルジョン原液21を調製した。この原液21をアルミニウム性耐圧容器に100g充填し、エアゾールバルブを取り付け、容器内の圧力が0.6MPa(25℃)となるように炭酸ガスを充填し、発泡性エアゾール組成物を製造した。
Example 21
An oil phase and an aqueous phase shown in Table 5 were prepared, and the aqueous phase was added to the oil phase and stirred to prepare a water-in-oil emulsion stock solution 21. 100 g of this stock solution 21 was filled in an aluminum pressure-resistant container, an aerosol valve was attached, and carbon dioxide gas was filled so that the pressure in the container was 0.6 MPa (25 ° C.) to produce a foamable aerosol composition.
実施例22
原液22を用いたこと以外は実施例21と同様にして発泡性エアゾール組成物を製造した。
Example 22
A foamable aerosol composition was produced in the same manner as in Example 21 except that the stock solution 22 was used.
実施例23
原液23を用いたこと以外は実施例21と同様にして発泡性エアゾール組成物を製造した。
Example 23
A foamable aerosol composition was produced in the same manner as in Example 21 except that the stock solution 23 was used.
実施例24
表6に示す油相、水相をそれぞれ調製し、水相を油相に添加して攪拌し、油中水型エマルジョン原液24を調製した。この原液24をアルミニウム性耐圧容器に100g充填し、エアゾールバルブを取り付け、容器内の圧力が0.6MPa(25℃)となるように炭酸ガスを充填し、発泡性エアゾール組成物を製造した。
Example 24
An oil phase and an aqueous phase shown in Table 6 were prepared, and the aqueous phase was added to the oil phase and stirred to prepare a water-in-oil emulsion stock solution 24. 100 g of this stock solution 24 was filled in an aluminum pressure-resistant container, an aerosol valve was attached, and carbon dioxide gas was filled so that the pressure in the container was 0.6 MPa (25 ° C.) to produce a foamable aerosol composition.
実施例25
原液25を用いたこと以外は実施例24と同様にして発泡性エアゾール組成物を製造した。
Example 25
A foamable aerosol composition was produced in the same manner as in Example 24 except that the stock solution 25 was used.
実施例26
原液26を用いたこと以外は実施例24と同様にして発泡性エアゾール組成物を製造した。
Example 26
A foamable aerosol composition was produced in the same manner as in Example 24 except that the stock solution 26 was used.
比較例1
表7に示す油相、水相をそれぞれ調製し、水相を油相に添加して攪拌し、油中水型エマルジョン原液27を調製した。この原液27をアルミニウム性耐圧容器に100g充填し、エアゾールバルブを取り付け、容器内の圧力が0.6MPa(25℃)となるように炭酸ガスを充填し、発泡性エアゾール組成物を製造した。
Comparative Example 1
An oil phase and an aqueous phase shown in Table 7 were prepared, and the aqueous phase was added to the oil phase and stirred to prepare a water-in-oil emulsion stock solution 27. 100 g of this stock solution 27 was filled in an aluminum pressure-resistant container, an aerosol valve was attached, and carbon dioxide gas was filled so that the pressure in the container was 0.6 MPa (25 ° C.) to produce a foamable aerosol composition.
比較例2
原液28を用いたこと以外は比較例1と同様にして発泡性エアゾール組成物を製造した。
Comparative Example 2
A foamable aerosol composition was produced in the same manner as in Comparative Example 1 except that the stock solution 28 was used.
比較例3
原液29を用いたこと以外は比較例1と同様にして発泡性エアゾール組成物を製造した。
Comparative Example 3
A foamable aerosol composition was produced in the same manner as in Comparative Example 1 except that the stock solution 29 was used.
比較例4
原液1をアルミニウム性耐圧容器に100g充填し、エアゾールバルブを取り付け、容器内の圧力が0.6MPa(25℃)となるように窒素ガスを充填し、発泡性エアゾール組成物を製造した。
Comparative Example 4
100 g of the stock solution 1 was filled in an aluminum pressure-resistant container, an aerosol valve was attached, and nitrogen gas was filled so that the pressure in the container was 0.6 MPa (25 ° C.) to produce a foamable aerosol composition.
比較例5
原液1をアルミニウム性耐圧容器に90g充填し、エアゾールバルブを取り付け、液化石油ガス10gを充填し、発泡性エアゾール組成物を製造した。
Comparative Example 5
90 g of the stock solution 1 was filled in an aluminum pressure-resistant container, an aerosol valve was attached, and 10 g of liquefied petroleum gas was filled to produce a foamable aerosol composition.
比較例6
原液1をアルミニウム性耐圧容器に90g充填し、エアゾールバルブを取り付け、ジメチルエーテル10gを充填し、発泡性エアゾール組成物を製造した。
Comparative Example 6
90 g of the stock solution 1 was filled in an aluminum pressure-resistant container, an aerosol valve was attached, and 10 g of dimethyl ether was filled to produce a foamable aerosol composition.
比較例7
原液1をアルミニウム性耐圧容器に90g充填し、エアゾールバルブを取り付け、液化石油ガス10gを充填した。さらに、容器内の圧力が0.6MPa(25℃)となるように炭酸ガスを充填し、発泡性エアゾール組成物を製造した。
Comparative Example 7
Stock solution 1 was filled in 90 g of an aluminum pressure-resistant container, an aerosol valve was attached, and 10 g of liquefied petroleum gas was filled. Further, carbon dioxide gas was filled so that the pressure in the container was 0.6 MPa (25 ° C.) to produce a foamable aerosol composition.
比較例8
原液1をアルミニウム性耐圧容器に90g充填し、エアゾールバルブを取り付け、ジメチルエーテル10gを充填し、容器内の圧力が0.6MPa(25℃)となるように炭酸ガスを充填し、発泡性エアゾール組成物を製造した。
Comparative Example 8
90 g of the stock solution 1 is filled in an aluminum pressure-resistant container, an aerosol valve is attached, 10 g of dimethyl ether is filled, carbon dioxide is filled so that the pressure in the container is 0.6 MPa (25 ° C.), and a foamable aerosol composition Manufactured.
試験評価
得られたサンプルを25℃の恒温水槽に1時間浸漬し、下記の試験項目について評価した。
Test Evaluation The obtained sample was immersed in a constant temperature water bath at 25 ° C. for 1 hour, and the following test items were evaluated.
1.乳化状態
油相に水相を添加し、ホモミキサーを用いて1分間攪拌したときの乳化状態を評価した。
◎:乳化し、3時間静置しても安定している。
○:乳化し、3時間静置すると一部が分離する。
△:一時的に乳化しているが、すぐに分離する。
×:乳化していない。
1. Emulsified state The water phase was added to the oil phase, and the emulsified state when stirring for 1 minute using a homomixer was evaluated.
A: Emulsified and stable even after standing for 3 hours.
○: Emulsified and partly separated after standing for 3 hours.
Δ: Emulsified temporarily, but separated immediately.
X: Not emulsified.
2.発泡性
エアゾール組成物を1g吐出したときの発泡性を評価した。
◎:きめ細かく立体的なフォームを形成した。
○:立体的なフォームを形成した。
△:平面的なフォームを形成した。
×:ほとんど発泡もしくは崩れた粗いフォームであり、すぐに液状になった。
2. Foamability The foamability when 1 g of the aerosol composition was discharged was evaluated.
A: A fine and three-dimensional foam was formed.
○: A three-dimensional foam was formed.
Δ: A planar foam was formed.
X: A rough foam almost foamed or collapsed and immediately became liquid.
処方例1.日焼け止め用フォーム
下記の油中水型原液を調整し、アルミニウム製容器に充填した。容器にエアゾールバルブを取り付け、容器内部の平衡圧力が0.6MPaとなるようにステムから炭酸ガスを充填した。
<油中水型エマルジョン原液>
ホホバオイル(*1) 31.8
ジポリヒドロシキステアリン酸PEG−30(*2) 2.5
モノラウリン酸ジグリセリル(*4) 5.0
トリオレイン酸ペンタグリセリル(*5) 3.0
パラメトキシケイ皮酸2−エチルヘキシル(*24) 8.0
4−tert−ブチル−4’−メトキシジベンゾイルメタン(*25) 1.0
メチルパラベン 0.1
精製水 48.6
合計 100.0(重量%)
*24:ユビナールMC80(商品名)、BAFS(株)製
*25:パルソール1789(商品名)、BAFS(株)製
Formulation Example 1 Sunscreen foam The following water-in-oil stock solution was prepared and filled in an aluminum container. An aerosol valve was attached to the container, and carbon dioxide gas was filled from the stem so that the equilibrium pressure inside the container was 0.6 MPa.
<Water-in-oil emulsion stock solution>
Jojoba oil (* 1) 31.8
Dipolyhydroxystearic acid PEG-30 (* 2) 2.5
Diglyceryl monolaurate (* 4) 5.0
Pentaglyceryl trioleate (* 5) 3.0
2-Ethylhexyl paramethoxycinnamate (* 24) 8.0
4-tert-butyl-4′-methoxydibenzoylmethane (* 25) 1.0
Methylparaben 0.1
Purified water 48.6
Total 100.0 (% by weight)
* 24: Yubinar MC80 (trade name), manufactured by BAFS Corporation * 25: Pulsol 1789 (trade name), manufactured by BAFS Corporation
処方例2.パック用フォーム
下記の油中水型原液を調整し、アルミニウム製容器に充填した。容器にエアゾールバルブを取り付け、容器内部の平衡圧力が0.6MPaとなるようにステムから炭酸ガスを充填した。
<油中水型エマルジョン原液>
ホホバオイル(*1) 38.8
セタノール 2.0
ジポリヒドロシキステアリン酸PEG−30(*2) 2.5
モノラウリン酸ジグリセリル(*4) 5.0
トリオレイン酸ペンタグリセリル(*5) 3.0
メチルパラベン 0.1
精製水 48.6
合計 100.0(重量%)
Formulation Example 2 Foam for pack The following water-in-oil stock solution was prepared and filled in an aluminum container. An aerosol valve was attached to the container, and carbon dioxide gas was filled from the stem so that the equilibrium pressure inside the container was 0.6 MPa.
<Water-in-oil emulsion stock solution>
Jojoba oil (* 1) 38.8
Cetanol 2.0
Dipolyhydroxystearic acid PEG-30 (* 2) 2.5
Diglyceryl monolaurate (* 4) 5.0
Pentaglyceryl trioleate (* 5) 3.0
Methylparaben 0.1
Purified water 48.6
Total 100.0 (% by weight)
処方例3.クレンジング用フォーム
下記の油中水型原液を調整し、アルミニウム製容器に充填した。容器にエアゾールバルブを取り付け、容器内部の平衡圧力が0.6MPaとなるようにステムから炭酸ガスを充填した。
<油中水型エマルジョン原液>
ホホバオイル(*1) 37.8
コハク酸ジエトキシエチル 3.0
ジポリヒドロシキステアリン酸PEG−30(*2) 2.5
モノラウリン酸ジグリセリル(*4) 5.0
トリオレイン酸ペンタグリセリル(*5) 3.0
メチルパラベン 0.1
精製水 48.6
合計 100.0(重量%)
Formulation Example 3 Cleansing foam The following water-in-oil stock solution was prepared and filled in an aluminum container. An aerosol valve was attached to the container, and carbon dioxide gas was filled from the stem so that the equilibrium pressure inside the container was 0.6 MPa.
<Water-in-oil emulsion stock solution>
Jojoba oil (* 1) 37.8
Diethoxyethyl succinate 3.0
Dipolyhydroxystearic acid PEG-30 (* 2) 2.5
Diglyceryl monolaurate (* 4) 5.0
Pentaglyceryl trioleate (* 5) 3.0
Methylparaben 0.1
Purified water 48.6
Total 100.0 (% by weight)
Claims (6)
前記乳化剤が、HLBが2〜7.5の親油性界面活性剤であり、
油中水型エマルジョンを形成する原液と、
溶解性圧縮ガスとからなる発泡性エアゾール組成物。 Contains oil-based solvent, emulsifier, foaming agent, water,
The emulsifier is a lipophilic surfactant having an HLB of 2 to 7.5,
A stock solution to form a water-in-oil emulsion;
A foamable aerosol composition comprising a soluble compressed gas.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009165038A JP5730474B2 (en) | 2009-07-13 | 2009-07-13 | Foamable aerosol composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009165038A JP5730474B2 (en) | 2009-07-13 | 2009-07-13 | Foamable aerosol composition |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2011020929A true JP2011020929A (en) | 2011-02-03 |
JP5730474B2 JP5730474B2 (en) | 2015-06-10 |
Family
ID=43631322
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2009165038A Active JP5730474B2 (en) | 2009-07-13 | 2009-07-13 | Foamable aerosol composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5730474B2 (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013080127A3 (en) * | 2011-11-29 | 2013-11-07 | L'oreal | Cosmetic mousse composition comprising oil |
JP2013241347A (en) * | 2012-05-18 | 2013-12-05 | Daizo:Kk | Foamable aerosol composition |
JP2014156416A (en) * | 2013-02-15 | 2014-08-28 | Fancl Corp | Foam cosmetic preparation |
JP2015000871A (en) * | 2013-06-18 | 2015-01-05 | ロレアル | Foam aerosol cosmetic composition |
JP2016193838A (en) * | 2015-03-31 | 2016-11-17 | 株式会社ナリス化粧品 | Skin cleansing composition |
JP2018027907A (en) * | 2016-08-17 | 2018-02-22 | 日進化学株式会社 | Oil foam aerosol composition |
JP2020040899A (en) * | 2018-09-07 | 2020-03-19 | 株式会社ダイゾー | Foamable composition |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108499162A (en) * | 2018-03-09 | 2018-09-07 | 国家***天津海水淡化与综合利用研究所 | Sea water desalination antifoaming agent and its preparation method and application |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS62502194A (en) * | 1985-03-18 | 1987-08-27 | プロダクト・リソ−シズ・インタ−ナショナル・インコ−ポレイテッド | aerosol foam |
JPH03133915A (en) * | 1989-10-19 | 1991-06-07 | Shiseido Co Ltd | Water-in-oil type emulsified foam cosmetic |
JP2001072963A (en) * | 1999-09-03 | 2001-03-21 | Daizo:Kk | Water-in-oil type bubblelike aerosol composition and preparation thereof |
JP2001181609A (en) * | 1999-12-27 | 2001-07-03 | Daizo:Kk | Aerosol composition |
JP2003292415A (en) * | 2002-04-01 | 2003-10-15 | Shin Etsu Chem Co Ltd | Cosmetic |
-
2009
- 2009-07-13 JP JP2009165038A patent/JP5730474B2/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS62502194A (en) * | 1985-03-18 | 1987-08-27 | プロダクト・リソ−シズ・インタ−ナショナル・インコ−ポレイテッド | aerosol foam |
JPH03133915A (en) * | 1989-10-19 | 1991-06-07 | Shiseido Co Ltd | Water-in-oil type emulsified foam cosmetic |
JP2001072963A (en) * | 1999-09-03 | 2001-03-21 | Daizo:Kk | Water-in-oil type bubblelike aerosol composition and preparation thereof |
JP2001181609A (en) * | 1999-12-27 | 2001-07-03 | Daizo:Kk | Aerosol composition |
JP2003292415A (en) * | 2002-04-01 | 2003-10-15 | Shin Etsu Chem Co Ltd | Cosmetic |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013080127A3 (en) * | 2011-11-29 | 2013-11-07 | L'oreal | Cosmetic mousse composition comprising oil |
JP2013241347A (en) * | 2012-05-18 | 2013-12-05 | Daizo:Kk | Foamable aerosol composition |
JP2014156416A (en) * | 2013-02-15 | 2014-08-28 | Fancl Corp | Foam cosmetic preparation |
JP2015000871A (en) * | 2013-06-18 | 2015-01-05 | ロレアル | Foam aerosol cosmetic composition |
JP2016193838A (en) * | 2015-03-31 | 2016-11-17 | 株式会社ナリス化粧品 | Skin cleansing composition |
JP2018027907A (en) * | 2016-08-17 | 2018-02-22 | 日進化学株式会社 | Oil foam aerosol composition |
JP2020040899A (en) * | 2018-09-07 | 2020-03-19 | 株式会社ダイゾー | Foamable composition |
JP7108502B2 (en) | 2018-09-07 | 2022-07-28 | 株式会社ダイゾー | Effervescent composition |
Also Published As
Publication number | Publication date |
---|---|
JP5730474B2 (en) | 2015-06-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5730474B2 (en) | Foamable aerosol composition | |
US10369102B2 (en) | Wax foamable vehicle and pharmaceutical compositions thereof | |
JP5937007B2 (en) | Foamable aerosol composition | |
JP4173034B2 (en) | Aerosol composition | |
JP5661253B2 (en) | Aerosol composition | |
JP2014073991A (en) | Emulsion composition | |
JP2011195510A (en) | Oil-in-water type emulsified skin external composition | |
KR20010006167A (en) | Oil-in-water type emulsified compositions | |
JP2006290762A (en) | Oil-in-water emulsified composition | |
JP6022140B2 (en) | Aerosol composition | |
JP2010006738A (en) | Foamable aerosol composition | |
JP2002275029A (en) | W/o/w type emulsified cosmetic | |
JP5044106B2 (en) | Aerosol composition for human body containing vitamins | |
JP2011195511A (en) | Oil-in-water type emulsified skin external composition | |
JP5180601B2 (en) | Aerosol composition | |
JP4972895B2 (en) | Urea formulation for external use | |
JP6932078B2 (en) | Oil-in-water emulsified composition and aerosol cosmetics | |
JP2018039789A (en) | Composition | |
JP7278748B2 (en) | Aerosol type water-in-oil deodorant spray | |
JP2004217616A (en) | Oil-in-water emulsion composition and production method therefor | |
JP5341397B2 (en) | Aerosol composition | |
JP5140298B2 (en) | Spray composition and spray product comprising said composition | |
JP3634139B2 (en) | Oil-in-water emulsion composition | |
JP2015168627A (en) | oil-in-water type cosmetic | |
JP2018118958A (en) | Emulsified composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20120525 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20130823 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130903 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20131031 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20140610 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20140729 |
|
RD02 | Notification of acceptance of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7422 Effective date: 20140729 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20150217 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20150311 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20150407 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20150408 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5730474 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |